December 17, 2019

Is your staff ready to manage malignant hyperthermia?

Malignant hyperthermia (MH) is a rare but life-threatening surgical complication that seems to turn the effects of general anesthesia upside down. Instead of relaxing, muscles become rigid, releasing large amounts of acid and potassium into the blood. Instead of a normal slowing of breathing, respirations quicken, and end-tidal CO2 rises. Other signs include tachycardia and a spike in body temperature that can reach over 110°F. Without rapid treatment, MH can lead to cardiac arrest and death.

Welcome to OR Manager, your source of information and insight into the clinical and business management of the surgical suite. This article is only available to OR Manager subscribers. To read this article, and gain access to all OR Manager resources, please log in below:

LOGIN

Not a subscriber? That’s OK, subscribe today! OR Manager offers all-access subscriptions at an affordable rate. With your subscription – or your team’s group subscription – you’ll receive access to all that OR Manager has to offer, including our monthly issues, CE credit opportunities, job postings, and discounts to our industry-leading conferences.

Explore Subscription Options

Please contact our Customer Service Team if you are unable to log in at clientservices@accessintel.com or 1-888-707-5814.

Get OR Manager Updates

Sign Up Now
Latest Issue of OR Manager
December 2022
Video Spotlight
Live chat by BoldChat